Latest news
Amphastar Pharmaceuticals (NASDAQ:AMPH) Upgraded by Wall Street Zen to "Strong-Buy" Rating - MarketBeatMarketBeat · Sat, 08 Aug 2026 06:21:23 GMTAmphastar Pharmaceuticals (NASDAQ:AMPH) Price Target Cut to $20.00 by Analysts at Piper Sandler - MarketBeatMarketBeat · Fri, 07 Aug 2026 17:02:18 GMTWells Fargo & Company Increases Amphastar Pharmaceuticals (NASDAQ:AMPH) Price Target to $20.00 - MarketBeatMarketBeat · Fri, 07 Aug 2026 14:54:55 GMTAmphastar Pharmaceuticals (NASDAQ:AMPH) Shares Gap Up After Strong Earnings - MarketBeatMarketBeat · Fri, 07 Aug 2026 14:23:37 GMTAmphastar Pharmaceuticals (NASDAQ:AMPH) Releases Quarterly Earnings Results, Beats Expectations By $0.29 EPS - MarketBeatMarketBeat · Fri, 07 Aug 2026 02:14:15 GMTAmphastar Pharmaceuticals Q2 Earnings Call Highlights - MarketBeatMarketBeat · Fri, 07 Aug 2026 00:25:41 GMTPacer Advisors Inc. Buys 83,739 Shares of Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeatMarketBeat · Thu, 06 Aug 2026 09:24:43 GMTAmphastar Pharmaceuticals, Inc. $AMPH Shares Bought by Dimensional Fund Advisors LP - MarketBeatMarketBeat · Tue, 04 Aug 2026 10:37:12 GMT